Results: Ninety-seven EPMs were diagnosed in 92 patients (23.6%), among them 78 (80.4%) were previous, 14 (14.4%) were synchronous and 5 (5.2%) were metachronous. O/E ratios for prevalent EPMs were significantly increased for colorectal carcinoma (2.26; CI 95% 1.17-3.96), renal cell carcinoma (6.00; CI 95% 2.74-11.39) and thyroid carcinoma (5.56; CI 95% 1.80-12.96). Increased age, heavy cigarette smoking, alcohol consumption and firstdegree family history of gastric cancer are significant risk factors for EPMs, while first-degree family history of colorectal carcinoma was borderline.
Conclusion:
We report an increased prevalence of EPMs in Italian patients with IPMN, especially for colorectal carcinoma, renal cell and thyroid cancers. A systematic surveillance of IPMN cases for such cancer types would be advised. Key words: epidemiology, risk factors, IPMN, extrapancreatic malignancies introduction Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are mucin-producing epithelial tumors that show a papillary architecture and are associated with dilatation of the ducts [1] . Since IPMNs were first reported as unique pathohistological entity [2] , progresses were made in understanding their clinicopathological features [1, 3] , the tools for their diagnosis and management [4] [5] [6] and the assessment of their potential for malignancy [7, 8] . These findings, combined with the increased availability for imaging diagnostics, led to an increase in the incidence of IPMNs [9] [10] [11] .
It is acknowledged that IPMN patients have an additional risk of developing pancreatic ductal adenocarcinoma (PDAC) [12] and extrapancreatic malignances (EPMs) [13] . Since the first report was published in 1999 [13] , several studies reported that between 10% and 40% of IPMN patients are diagnosed with EPMs [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . Colorectal cancer [18, 20, 21, 23] , gastric cancer [13-17, 19, 22] , lung and breast cancers [18, 19] are among the most common EPMs diagnosed in IPMN patients. Increasing age and positive family history for colorectal cancer are reported as the main risk factors for EPMs among IPMNs [13, 15, 17-19, 23, 24] , with some studies suggesting a potential role of the genetic background [25, 26] . The prognosis of IPMNs is generally favorable, with a 5-year survival rate around 60%-70% for the noninvasive forms, and 30%-40% for the invasive forms [9, 27] . Nevertheless, among those who develop EPMs, the prognosis is less favorable [13] [14] [15] 19] . With exception of one study reporting on the occurrence and risk factors of EPMs among IPMNs in a European population [21] , all those studies were conducted in Asia [13-17, 19, 22, 24] or in the United States [18, 20] .
The objective of our multicenter study was to assess the prevalence and incidence of EPMs in a cohort of Italian patients diagnosed with IMPN, and to identify the risk factors for their occurrence.
methods study design and population
A hospital-based multicenter study was conducted at the participating centers upon Hospital Review Boards approval [28] . All participating centers are named in supplementary file available at Annals of Oncology online containing detailed methodology. Prevalent cases of patients with either a new diagnosis of IPMN or those seen during follow-up at the participating units during an 18-month period (January 2010 to June 2011) were enrolled. Inclusion criteria were: (a) age >18 years old; (b) will and ability to cooperate. The criteria for the identification of IPMN cases are described previously [7] . Patients were excluded if they have cystic lesions other than IPMN. The type of duct involvement was determined at each participating unit by revision of clinical imaging studies and of macroscopic and microscopic examinations when available, and classified as either main duct (MD-IPMNs), branch duct (BD-IPMNs) or combined (C-IPMNs).
EPMs were defines as secondary primary tumor occurring in IPMN patients, with a histological confirmation. EPMs were grouped according to the time of their diagnosis: (1) previous EPMs, which were diagnosed before the IPMN diagnosis; (2) synchronous EPMs, diagnosed at the same time of IPMN; (3) metachronous EPMs, diagnosed during the follow-up of IPMN patients. We considered previous and synchronous as prevalent EPMs, while metachronous as incident EPMs. IPMN cases were followedup for an average period of 13 months (5-31 months). The follow-up for each individual patient was scheduled according with published guidelines (4), and included abdominal ultrasound, computed tomography, magnetic resonance imaging or endoscopic ultrasound. Additional investigations, such as gastroscopy, colonoscopy or chest x-ray, were carried out when judged to be clinically indicated, while no standard screening procedures were carried out. IPMN patients were interviewed by a trained physician who filled-in a structured questionnaire to collect data on demographics, medical and family history and lifestyle habits. Additional details on the variables collected are available in the supplementary File S1, available at Annals of Oncology online.
statistical analysis
For previous and synchronous EPMs ( prevalent EPMs), the ratio of the observed (O) number of patients with EPMs to the expected (E) number was calculated along with 95% confidence interval (CI) [29] . We excluded in this calculation the metachronous tumors (incident EPMs) in view of the short follow-up. Data on age-stratified and gender-specific prevalence of cancer in Italy were used to determine the expected number of EPMs [30] . We compared the distribution of the demographics, medical and family history, lifestyle habits variables among patients with and without EPMs by univariate analysis. Chi-square and Fisher's exact tests were used where appropriate.
Statistical analyses were carried out using Stata 11. Table S1 , available at Annals of Oncology online). Four cases of PDACs (one previous and three synchronous) and three pancreatic neuroendocrine tumors (all of them synchronous) were also diagnosed (data not shown).
The ratios between O/E previous and synchronous EPMs are reported in Table 2 By comparing IPMN patients with and without EPMs (Table 3) , increasing age (P = 0.011), ever alcohol consumption (P = 0.039) and first-degree family history of gastric cancer (P = 0.033) were the main risk factor for EPMs, while firstdegree family history of colorectal carcinoma was borderline (P = 0.051) ( Table 3 ). Although we did not observe that EPMs are significantly more common in ever smokers compared with never smokers, those consuming ≥20 pack-years were more represented in patients with EPMs (P = 0.022). First-degree family history of PDAC (P = 0.009) and history of peptic ulcer (P = 0.035) were protective on the occurrence of EPMs. Lastly, the occurrence of EPMs was more frequent among nonsurgical IPMN patients (P = 0.059) ( Table 3) .
Since the first study [13] published in 1999 reported that 32% of 42 IPMN patients developed EPMs, additional studies were conducted, mainly in Asian populations [14, 15, 22] . Most of these, however, had a small number of patients (<100) [13, 14, 22] , and all suffered from recruitment bias as IPMN patients were all surgical, thus including mainly malignant IPMNs [13] [14] [15] 22] . These studies reported that the frequency of prevalent or incident EPMs was around 24.6%-39%. Additional studies including surgical IPMNs and not confirmed the higher frequencies of EPMs among IPMNs [16, 17, 19] , with the largest study in Asian population [17] reporting a prevalence of EPMs 33.8%. One study from the United States [20] reported a prevalence of EPMs of 40%, while the only study conducted in Europe reported an occurrence of 16.8% [21] . Unfortunately, most of these studies do not distinguish between prevalent and incident EPMs, so that results are hard to compare.
Our study showed significantly increased O/Es for colorectal cancer, renal cell carcinoma, thyroid and hematological cancers. Eguchi et al. [15] showed a significantly increased O/E number in the IPMN patients, especially for colorectal cancer. Riel et al. [18] reported increased risk for hepatobiliar, esophageal and gastrointestinal stromal tumors, and borderline significant risk for carcinoid and urinary tract tumors. Kawakubo et al. [24] carried out long-term follow-up of the 
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IPMN patients and did not find any increased standard incidence ratios (SIR) of EPMs. Although we diagnosed five metachronous cancers, our follow-up was too short to calculate SIRs. The follow-up is, however, undergoing so that additional reports on the incident of EPMs in our cohort are expected. Diagnostic bias might be an issue, as EPMs might be overestimated in IPMN patients respect to the general population as these subjects are usually under increased medical observation. We feel, however, to exclude the presence of this bias as the vast majority of EPMs were diagnosed previous or concomitant with IPMN diagnosis, with IPMN actually diagnosed soon after the EPMs diagnosis. On the basis of the increased incidence of colonic polyps among IPMN patients, Reid-Lombardo et al. actually recommended colonoscopy screening for IPMNs [20] . In view of these findings [15, 20] and our results, it is reasonable to suggest a colonoscopy screening for IPMN patients to early detect colonic polyps or colorectal carcinomas. Several studies showed that patients with IPMN have an increased risk of EPMs compared with those with PDAC [13-15, 20, 23] , even though this is not true for malignant IPMN [18] . In fact, several reports also suggest that an inverse association exists between IPMN malignant potential and EPM frequency [17, 22] . This observation was also confirmed in our study, as EPMs were borderline more frequently in nonsurgical IPMNs. IPMN is considered to be a precursor lesion for PDAC [31] , and patients with IPMNs have been reported to be at the increased risk to develop coexistent PDAC [12] . Our study showed an increased O/E ratio for PDAC in IPMNs, speaking in favor of the 'precursor lesion' theory. Unexpectedly, however, we observed a protective effect of first-degree family history of PDAC to occurrence of EPMs in IPMN patients. As patients with first-degree family history of PDAC are reported to more likely develop PDAC [32] , it is possible that the early onset of PDAC with aggressive progression could lead to insufficient time left for other EPMs to occur.
Our study confirmed the role of increased age as a risk factor for EPMs in IPMN [13, [17] [18] [19] 24] , which is expected also in view of the well-known increased risk of cancer overall in older population [33] . We identified first-degree family history of gastric cancer as a risk factor for EPMs, while firstdegree family history of colorectal carcinoma was borderline. A recent study in Japan reported that individuals with firstdegree family history of gastric cancer are at the increased risk to develop colorectal carcinoma [34] , and this supports our finding as colorectal carcinoma is the second most common form of EPMs. Still, this result needs to be confirmed in a larger study, as it might be a peculiar finding only among the IPMN patients. First-degree family history of colorectal carcinoma was reported as a risk factor for EPMs by Lubezky et al. [23] , while another report implicated that IPMNs are associated with familial adenomatous polyposis syndrome [26] . We were unable to find a significant association, although our borderline finding result is in line also with the knowledge that a large proportion of the EPMs are colorectal carcinoma, for which a positive family history is acknowledged [35] . Concerning cigarette smoking habits, our study confirms that smoke is not associated with EPMs [14, 21] , however we report that smokers who consumed ≥20 pack-years are more likely to have EPMs compared with <20 pack-years. Although alcohol has been previously investigated as a possible risk factor for EPMs among IPMNs [14, 21] , our study is the first reporting a significant association. As alcohol has been reported as one of the major contributors to cancer risk [36] , it is conceivable that it can influence the occurrence of EPMs. For the first time we report a protective effect of peptic ulcer history towards EPMs in IPMNs, which need to be further investigated within studies that collected this information. original articles
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In conclusion, our study comprising the largest set of IPMNs in Europe suggests that IPMNs are at higher risk of developing colorectal, renal cell and thyroid carcinoma, thus suggesting for a potential for a systematic surveillance of IPMN cases for these cancers especially if first-degree family history of gastric or colorectal cancer is present. Further investigations in other European populations are expected to confirm our findings.
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